Stevens Capital Management LP Sells 18,602 Shares of MetLife, Inc. (NYSE:MET)

Stevens Capital Management LP decreased its holdings in MetLife, Inc. (NYSE:MET - Free Report) by 49.0% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 19,396 shares of the financial services provider's stock after selling 18,602 shares during the period. Stevens Capital Management LP's holdings in MetLife were worth $1,283,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds also recently bought and sold shares of the company. Pzena Investment Management LLC boosted its position in shares of MetLife by 118.1% in the 3rd quarter. Pzena Investment Management LLC now owns 10,108,992 shares of the financial services provider's stock worth $635,957,000 after purchasing an additional 5,474,449 shares in the last quarter. DekaBank Deutsche Girozentrale boosted its holdings in MetLife by 806.2% in the third quarter. DekaBank Deutsche Girozentrale now owns 1,607,195 shares of the financial services provider's stock worth $100,152,000 after acquiring an additional 1,429,840 shares in the last quarter. AEGON ASSET MANAGEMENT UK Plc purchased a new stake in shares of MetLife during the fourth quarter worth about $52,752,000. FMR LLC increased its holdings in shares of MetLife by 54.1% during the third quarter. FMR LLC now owns 2,126,683 shares of the financial services provider's stock valued at $133,790,000 after acquiring an additional 746,643 shares in the last quarter. Finally, J.P. Morgan Private Wealth Advisors LLC purchased a new position in shares of MetLife in the 3rd quarter valued at approximately $38,669,000. Hedge funds and other institutional investors own 89.81% of the company's stock.

Wall Street Analysts Forecast Growth


A number of research analysts have issued reports on MET shares. Wells Fargo & Company upped their price target on shares of MetLife from $83.00 to $86.00 and gave the company an "overweight" rating in a research note on Thursday, April 11th. Morgan Stanley lifted their price target on MetLife from $80.00 to $82.00 and gave the stock an "overweight" rating in a research report on Monday, April 15th. The Goldman Sachs Group upgraded MetLife from a "neutral" rating to a "buy" rating and raised their price objective for the stock from $70.00 to $80.00 in a research note on Monday, January 8th. UBS Group dropped their price objective on shares of MetLife from $87.00 to $82.00 and set a "buy" rating on the stock in a report on Monday, February 5th. Finally, Piper Sandler upped their price target on shares of MetLife from $74.00 to $85.00 and gave the company an "overweight" rating in a report on Friday, April 5th. Two investment analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company. Based on data from MarketBeat.com, MetLife currently has an average rating of "Moderate Buy" and an average price target of $79.23.

Read Our Latest Report on MetLife

Insider Buying and Selling at MetLife

In related news, insider Ramy Tadros sold 4,026 shares of the company's stock in a transaction on Wednesday, March 13th. The shares were sold at an average price of $71.90, for a total value of $289,469.40. Following the completion of the sale, the insider now owns 146,981 shares in the company, valued at approximately $10,567,933.90. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. In related news, EVP Bill Pappas sold 27,000 shares of MetLife stock in a transaction dated Monday, March 18th. The stock was sold at an average price of $72.27, for a total transaction of $1,951,290.00. Following the completion of the sale, the executive vice president now owns 57,768 shares in the company, valued at approximately $4,174,893.36. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, insider Ramy Tadros sold 4,026 shares of MetLife stock in a transaction dated Wednesday, March 13th. The stock was sold at an average price of $71.90, for a total transaction of $289,469.40. Following the sale, the insider now owns 146,981 shares of the company's stock, valued at $10,567,933.90. The disclosure for this sale can be found here. 0.32% of the stock is owned by company insiders.

MetLife Trading Down 2.1 %

NYSE:MET traded down $1.48 on Friday, reaching $70.42. 5,586,911 shares of the company's stock were exchanged, compared to its average volume of 3,532,651. The business has a fifty day moving average of $71.41 and a 200-day moving average of $67.09. The company has a quick ratio of 0.16, a current ratio of 0.16 and a debt-to-equity ratio of 0.53. MetLife, Inc. has a 52-week low of $48.95 and a 52-week high of $74.68. The firm has a market capitalization of $50.92 billion, a price-to-earnings ratio of 39.29, a price-to-earnings-growth ratio of 0.55 and a beta of 1.04.

MetLife (NYSE:MET - Get Free Report) last announced its quarterly earnings data on Wednesday, January 31st. The financial services provider reported $1.93 EPS for the quarter, missing analysts' consensus estimates of $1.95 by ($0.02). The company had revenue of $18.72 billion for the quarter, compared to analyst estimates of $18.07 billion. MetLife had a return on equity of 19.48% and a net margin of 2.36%. As a group, analysts expect that MetLife, Inc. will post 8.71 earnings per share for the current year.

MetLife Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 11th. Shareholders of record on Tuesday, May 7th will be paid a $0.545 dividend. This represents a $2.18 annualized dividend and a yield of 3.10%. The ex-dividend date is Monday, May 6th. This is an increase from MetLife's previous quarterly dividend of $0.52. MetLife's dividend payout ratio is currently 113.66%.

MetLife Company Profile

(Free Report)

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.

Read More

Institutional Ownership by Quarter for MetLife (NYSE:MET)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should you invest $1,000 in MetLife right now?

Before you consider MetLife, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MetLife wasn't on the list.

While MetLife currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Featured Articles and Offers

Search Headlines: